Literature DB >> 6163417

Interferon therapy: pharmacokinetic and pharmacological aspects.

A Billiau.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6163417     DOI： 10.1007/BF01318595

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


× No keyword cloud information.
  60 in total

1.  Double-blind study of interferon administration in renal transplant recipients.

Authors:  W Weimar; H Schellekens; L D Lameijer; N Masurel; V G Edy; A Billiau; P De Somer
Journal:  Eur J Clin Invest       Date:  1978-08       Impact factor: 4.686

2.  Comparison of rates of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits.

Authors:  V G Edy; A Billiau; P De Somer
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

3.  Circulating interferon in rabbits after administration of human interferon by different routes.

Authors:  K Cantell; L Pyhälä
Journal:  J Gen Virol       Date:  1973-07       Impact factor: 3.891

4.  Letter: Interferon in acute leukaemia in children.

Authors:  L Ahström; A Dohlwitz; H Strander; G Carlström; K Cantell
Journal:  Lancet       Date:  1974-02-02       Impact factor: 79.321

5.  Pyrogenicity of poly I. poly C in rabbits.

Authors:  H L Lindsay; P W Trown; J Brandt; M Forbes
Journal:  Nature       Date:  1969-08-16       Impact factor: 49.962

6.  Successful treatment of nasopharyngeal carcinoma with interferon.

Authors:  J Treuner; D Niethammer; G Dannecker; R Hagmann; V Neef; P H Hofschneider
Journal:  Lancet       Date:  1980-04-12       Impact factor: 79.321

7.  Tolerability of pure fibroblast interferon in man.

Authors:  A Billiau; J W Heine; J Van Damme; H Heremans; P De Somer
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

8.  Interferon therapy in neoplastic disease. A preliminary report.

Authors:  I S Christophersen; R Jordal; K Osther; J Lindenberg; P H Pedersen; K Berg
Journal:  Acta Med Scand       Date:  1978

9.  Correlation between fever and interferon titer in rabbits after induction with myxoviruses.

Authors:  R Siegert; H L Shu; H Kohlhage
Journal:  Life Sci       Date:  1967-03-15       Impact factor: 5.037

10.  Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro.

Authors:  E van 't Hull; H Schellekens; B Löwenberg; M J de Vries
Journal:  Cancer Res       Date:  1978-04       Impact factor: 12.701
View more
  9 in total

1.  Pharmacokinetics of recombinant interferon alpha-C.

Authors:  O Merimsky; M Rubinstein; D Fischer; A Danon; S Chaitchik
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Negative regulation of human astrocytes by interferon (IFN) α in relation to growth inhibition and impaired glucose utilization.

Authors:  Ting Wang; Yasuhiro Takikawa; Kei Sawara; Yuichi Yoshida; Kazuyuki Suzuki
Journal:  Neurochem Res       Date:  2012-05-25       Impact factor: 3.996

3.  Interferon inhibits the accumulation of glycerol phosphate dehydrogenase mRNA in oligodendrocytes and C6 cells.

Authors:  A C Passaquin; G Coupin; W A Schreier; P Poindron; R A Cole; J de Vellis
Journal:  Neurochem Res       Date:  1989-10       Impact factor: 3.996

Review 4.  The interferon system as a basis for antiviral therapy or prophylaxis.

Authors:  A Billiau
Journal:  Antiviral Res       Date:  1985       Impact factor: 5.970

5.  Subacute sclerosing panencephalitis in a brother and sister. Therapeutic trial of fibroblast interferon.

Authors:  C R Bartram; J Henke; J Treuner; M Basler; A Esch; W Mortier
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

Review 6.  The clinical application of fibroblast interferon--an overview.

Authors:  A Billiau
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

7.  The treatment of cancer patients with human lymphoblastoid interferon. A comparison of two routes of administration.

Authors:  J A Knost; S A Sherwin; P G Abrams; J J Ochs; K A Foon; R Williams; R Tuttle; R K Oldham
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

8.  Astrocytes produce interferon that enhances the expression of H-2 antigens on a subpopulation of brain cells.

Authors:  B Tedeschi; J N Barrett; R W Keane
Journal:  J Cell Biol       Date:  1986-06       Impact factor: 10.539

9.  Multicentre double-blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis.

Authors:  L Jacobs; A M Salazar; R Herndon; P A Reese; A Freeman; R Josefowicz; A Cuetter; F Husain; W A Smith; R Ekes
Journal:  Lancet       Date:  1986 Dec 20-27       Impact factor: 79.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.